Antikankermiddel 265
Gecertificeerd

Antikankermiddel 265

Catalog #: HY-I0450-01
Maat: 1 g

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC50 values ​​of 13.1, 11.7, and 14.6 μM, respectively[1].

CAS Number

184177-83-1

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Drug Derivative

Related Pathways

Others

Field of Research

Cancer

Purity

99.74

Smiles

O=C1N(C2=CC=C(N3CCN(C4=CC=C(O)C=C4)CC3)C=C2)C=NN1[C@@H](CC)[C@@H](OCC5=CC=CC=C5)C

Molecular Formula

C30H35N5O3

Molecular Weight

513.63

Precautions

H302, H315, H319, H335

References & Citations

[1]G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1- ((2S, 3S) -2- (benzyloxy) pentan-3-yl) -4- (4- (4- (4-hydroxyphenyl) piperazin-1-yl) phenyl) -1H-1, 2, 4-triazol-5 (4H) -one. Journal of Structural Chemistry 60.7 (2019) : 1173-1179.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-I0450/Anticancer-agent-265-SDS-MedChemExpress.pdf

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Beschrijving

Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U

Specificaties

ProductnaamAntikankermiddel 265
Categorie
Beschikbare grootte1 g
CatalogusnummerHY-I0450-01